{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:49:45Z","timestamp":1787755785664,"version":"build-2784847793"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001285","name":"UCL Institute of Ophthalmology, University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012617","name":"Moorfields Eye Hospital NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012617","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.oret.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T16:42:48Z","timestamp":1581439368000},"page":"689-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Aflibercept Reduces Retinal Hemorrhages and Intravitreal Microvascular Abnormalities But Not Venous Beading"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8010-228X","authenticated-orcid":false,"given":"Elizabeth","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-522X","authenticated-orcid":false,"given":"Victor","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-0659","authenticated-orcid":false,"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2020.02.003_bib1","doi-asserted-by":"crossref","unstructured":"Sivaprasad S, Hykin P, Prevost AT, et\u00a0al. Efficacy and mechanism evaluation. In: Intravitreal aflibercept compared with panretinal photocoagulation for proliferative diabetic retinopathy: the CLARITY non-inferiority RCT. Southampton, UK: NIHR Journals Library. Efficacy and Mechanism Evaluation, No 5.5 Queen's Printer and Controller of HMSO Oct 2018.","DOI":"10.3310\/eme05050"},{"key":"10.1016\/j.oret.2020.02.003_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.oret.2020.02.003_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.02.003_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Simo","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.oret.2020.02.003_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2020.02.003_bib6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0021-5155(01)00380-X","article-title":"Subclassification of preproliferative diabetic retinopathy and glycemic control: relationship between mean hemoglobin A1C value and development of proliferative diabetic retinopathy","volume":"45","author":"Sato","year":"2001","journal-title":"Jpn J Ophthalmol"},{"issue":"1 Pt 2","key":"10.1016\/j.oret.2020.02.003_bib7","first-page":"1","article-title":"Report number 6. Design, methods, and baseline results. Report number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy","volume":"21","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5 Suppl","key":"10.1016\/j.oret.2020.02.003_bib8","first-page":"823","article-title":"Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"10.1016\/j.oret.2020.02.003_bib9","first-page":"786","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2014an extension of the modified Airlie House classification. ETDRS report number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2020.02.003_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00417-018-3971-3","article-title":"Venous beading in two or more quadrants might not be a sensitive grading criterion for severe nonproliferative diabetic retinopathy","volume":"256","author":"Chen","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2020.02.003_bib11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archophthalmol.2012.1043","article-title":"Long-term effects of ranibizumab on diabetic retinopathy severity and progression","volume":"130","author":"Ip","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.02.003_bib12","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/bjophthalmol-2017-310664","article-title":"Impact of baseline diabetic retinopathy severity scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies","volume":"102","author":"Staurenghi","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2020.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008405","article-title":"Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial","volume":"5","author":"Sivaprasad","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.oret.2020.02.003_bib14","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.oret.2020.02.003_bib15","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1167\/iovs.17-23509","article-title":"Mechanistic evaluation of panretinal photocoagulation versus aflibercept in proliferative diabetic retinopathy: CLARITY substudy","volume":"59","author":"Nicholson","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2020.02.003_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archophthalmol.2010.347","article-title":"Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape","volume":"129","author":"Wong","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2020.02.003_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41433-019-0342-1","article-title":"Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab","volume":"33","author":"Talks","year":"2019","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2020.02.003_bib18","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1111\/aos.14106","article-title":"Comparing diabetic retinopathy lesions in scanning laser ophthalmoscopy and colour fundus photography","volume":"97","author":"Nghiem","year":"2019","journal-title":"Acta Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653020300580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:51Z","timestamp":1762853271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653020300580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2468653020300580"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2020.02.003","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aflibercept Reduces Retinal Hemorrhages and Intravitreal Microvascular Abnormalities But Not Venous Beading","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}